Negar Morovatdar

Negar Morovatdar

Auto-generated profile, based on publicly available information

Negar Morovatdar

Clinical Research Unit, Imam Reza Hospital Mashhad University of Medical Sciences Mashhad Iran

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
MAMahmoud Reza Azarpazhooh
Mahmoud Reza Azarpazhooh
NMNegar Morovatdar
Negar Morovatdar
AAAbolfazl Avan
Abolfazl Avan
TPThanh G Phan
Thanh G Phan
ADAfshin A. Divani
Afshin A. Divani
MNMario Di Napoli
Mario Di Napoli

30 April 2019 in European Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
HPHoorak Poorzand
Hoorak Poorzand
Konstantinos TsarouhasKonstantinos Tsarouhas
Konstantinos Tsarouhas
SHSeyyed Amin Hozhabrossadati
Seyyed Amin Hozhabrossadati
NKNastaran Khorrampazhouh
Nastaran Khorrampazhouh
YBYones Bondarsahebi
Yones Bondarsahebi
NMNegar Morovatdar
Negar Morovatdar
Background: The aim of this study was to determine the mean age at which coronary artery disease (CAD) hase decreased in recent years in Iran. This systematic review and meta‐analysis compares the prevalence of different risk factors of premature CAD (PCAD) in patients vs healthy individuals.Methods: Medline, Web of Science, Embase and Scientific Information Database were searched for studies about PCAD risk factors in Iran until 28 October 2017. Observational studies of Iranians, comparing risk factors between patients with PCAD and age‐ and sex‐matched healthy subjects, were included. Fixed‐effects and random‐effects model were used for pooling data. Odds ratio (OR) with 95% CI and mean difference were used for effect size estimation among studies.Results: Twelve studies were eligible for meta‐analysis. Diabetes mellitus (OR: 2.4, 95% CI: 1.9‐3.03; P = 0.0001, I2 = 25.5%; P = 0.2), family history of CAD (OR: 2.09, 95% CI: 1.22‐3.6; P = 0.007, I2 = 86%; P = 0.0001), dyslipidaemia (OR: 2.05, 95% CI: 1.15‐3.64; P = 0.01, I2 = 54%; P = 0.08), smoking (OR: 1.65, 95% CI: 1.11‐2.46; P = 0.01, I2 = 77.2%; P = 0.000) and hypertension (OR: 1.35, 95% CI: 1.21 to‐1.50; P < 0.001, I2 = 31%, P = 0.1) associated with PCAD. Sensitivity analysis demonstrated that patients with PCAD had significantly lower levels of high‐density lipoprotein (HDL) cholesterol and significantly higher levels of triglycerides compared to healthy subjects (MD: −2.56, 95% CI: −3.54 to −1.58, P < 0.001, I2 = 42%, P = 0.01 and MD: 21.17, 95% CI: 14.73‐27.62, P < 0.001, I2 = 80.12%, P < 0.001, respectively). It should be noted that although high levels of heterogeneity in LDL and HDL values among the studies were observed, when dyslipidaemia was studied as a binary variable, no significant heterogeneity among studies was observed.Conclusion: Diabetes mellitus, family history of CAD, dyslipidaemia, smoking, and hypertension were significantly and positively associated with CAD in young adults compared to healthy age‐ and sex‐matched population in Iran.

1 May 2021 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
NMNegar Morovatdar
Negar Morovatdar
AAAbolfazl Avan
Abolfazl Avan
MAMahmoud Reza Azarpazhooh
Mahmoud Reza Azarpazhooh
MNMario Di Napoli
Mario Di Napoli
SSSaverio Stranges
Saverio Stranges
VHVladimir Hachinski
Vladimir Hachinski

1 January 2022 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
SRSabah Rehman
Sabah Rehman
HPHoang T. Phan
Hoang T. Phan
MRMathew J. Reeves
Mathew J. Reeves
ATAmanda G. Thrift
Amanda G. Thrift
Dominique CadilhacDominique Cadilhac
Dominique Cadilhac
SGSeana Gall
Seana Gall

1 December 2020 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
AGAbdoreza Ghoreishi
Abdoreza Ghoreishi
SAShahram Arsang-Jang
Shahram Arsang-Jang
ZSZiad Sabaa-Ayoun
Ziad Sabaa-Ayoun
YNYassi Nawaf
Yassi Nawaf
PSP.N. Sylaja
P.N. Sylaja
MAMahmoud Reza Azarpazhooh
Mahmoud Reza Azarpazhooh

21 October 2023 in Artificial Intelligence in Medicine
Verified
Journal Article
Closed access
AYali yeganeh
ali yeganeh
Arne JohannssenArne Johannssen
Arne Johannssen
Nataliya ChukhrovaNataliya Chukhrova
Nataliya Chukhrova
MEMahdiyeh Erfanian
Mahdiyeh Erfanian
MAMahmoud Reza Azarpazhooh
Mahmoud Reza Azarpazhooh
NMNegar Morovatdar
Negar Morovatdar